Anne Lund Sorensen

Title: Anne Lund Sorensen: Innovator in Tuberculosis Vaccine Development

Introduction

Anne Lund Sorensen is a prominent inventor based in Bronshoj, Denmark. She has made significant contributions to the field of immunology, particularly in the development of vaccines for tuberculosis. Her innovative work has the potential to enhance the diagnosis and treatment of this serious infectious disease.

Latest Patents

Anne Lund Sorensen holds a patent for a novel tuberculosis vaccine. This invention relates to secreted antigens from mycobacteria that can evoke early immunological responses from T-helper cells. These responses occur within four days and involve gamma-interferon release in memory immune animals after rechallenge infection with mycobacteria of the tuberculosis complex. The antigens are derived from short-term filtrates of cultured mycobacteria. One identified antigen is a polypeptide with an apparent molecular weight of 6 kDa, for which the DNA encoding has been cloned and sequenced. The antigens are believed to be particularly useful in vaccines and diagnostic compositions for detecting infections with virulent mycobacteria.

Career Highlights

Anne Lund Sorensen is affiliated with the Statens Serum Institute, where she continues her research and development efforts. Her work has been instrumental in advancing the understanding of tuberculosis and improving vaccine efficacy.

Collaborations

Some of her notable coworkers include Kaare Haslov and Angse Bengaard Andersen. Their collaborative efforts contribute to the ongoing research and development in the field of immunology.

Conclusion

Anne Lund Sorensen's innovative work in tuberculosis vaccine development showcases her dedication to improving public health. Her contributions are vital in the fight against infectious diseases, and her patent reflects her commitment to advancing medical science.